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This article explores the recreational use of diverted dexamphetamine, a 
pharmaceutical stimulant, amongst a social network of young adults (aged 18-
31 years) in Perth, Western Australia (WA). Prior epidemiological research 
indicates that there are high levels of dexamphetamine prescription, and use 
of diverted dexamphetamine, in this jurisdiction. Little research exists on the 
social contexts of diverted dexamphetamine use in Australia or overseas. 
 
Methods 
Ethnographic fieldwork was conducted over 18 months among a network of 
approximately 60 young adults who regularly used psychostimulants. Data 
collection involved participant observation conducted in natural settings 
including nightclubs and private parties. In-depth interviews were also 
conducted with 25 key contacts which explored drug use histories and themes 
emerging from fieldwork. 
 
Results 
The use of diverted dexamphetamine, or ‘dexies’, was prevalent among the 
social network and integrated into local drug practices. The paper explores 
the ways in which dexamphetamine use is rationalised, negotiated and 
represented in the context of the use of alcohol and other psychostimulants 
such as methamphetamine and ecstasy. Two key aspects are emphasised. 
First, dexamphetamine use is seen as insignificant by network members and 
is positioned as ‘safer’ in relation to the use of other drugs by virtue of its 
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pharmaceutical status. Second, dexamphetamine plays an instrumental role 
in facilitating the pursuit of ‘controlled pleasure’ via the heavy consumption of 
alcohol and other drugs.  
 
Conclusion 
The findings of the paper have implications for harm reduction policy. In 
particular, dexamphetamine use facilitates heavy drinking and polydrug use 
among young adults, which may increase the harms associated with such 
use. Further, current interventions targeting young psychostimulant users, 
which emphasise their adulterated and illegal nature, may inadvertently 
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Introduction 
This article explores the recreational use of dexamphetamine, a 
pharmaceutical stimulant, amongst a social network of young adults (aged 18-
31 years) in Perth, Western Australia (WA). Dexamphetamine is a common 
name for dextroamphetamine sulphate, an amphetamine that stimulates the 
central nervous system by releasing dopamine, norepinephrine and serotonin 
(see Kuczenski & Segal, 1997). Its effects include reduced fatigue, elevated 
mood, increased feelings of well-being and confidence, and, in high doses, 
feelings of euphoria (see Zacny, Bodker, & de Wit, 1992). For these reasons, 
dexamphetamine is sometimes called ‘legalised speed’. 
 
Internationally, the pharmaceutical use of amphetamines dates back to the 
1930s when benzedrine inhalers were used to treat symptoms of the common 
cold (Iversen, 2006, p.2). Amphetamines have also been used in a variety of 
other medical settings including for the treatment of narcolepsy and 
depression. They have also been used, sometimes controversially, in military 
settings and professional sport (for a comprehensive historical overview of the 
use of amphetamines see Iversen, 2006; Rasmussen, 2008). Since the 
1980s, stimulants such as dexamphetamine and methylphenidate (or ‘Ritalin’) 
have been increasingly used for the management of Attention Deficit and 
Hyperactivity Disorder(s) (referred to collectively as ADHD) in children and 
adults (Kutcher et al., 2004).  
 
In Australia, dexamphetamine is marketed as ‘Dexedrine’ and ‘Dextrostat’. It 
is available only on medical prescription and is the only stimulant listed on the 
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Pharmaceutical Benefits Scheme, a government initiative that subsidises the 
cost of prescription drugs. Whereas in Australia, dexamphetamine is most 
commonly used to manage ADHD, in other countries Ritalin is the first line 
treatment and alternative preparations (including a non-stimulant, branded 
‘Strattera’) are also increasingly popular. 
 
The diverted use of pharmaceutical stimulants has received some attention in 
the international research literature (e.g. Kelly & Parsons, 2007) but very little 
in Australia. Public discussion of psychostimulant use in Australia tends to 
focus on methamphetamine and ecstasy and is characterised by 
sensationalist rhetoric and moral panic; only rarely does research focus on the 
views and experiences of young adults themselves (e.g. Gourley, 2004). 
Using ethnographic methods, we sought to understand the cultural meanings 
that shape, and are constituted through, recreational use of psychostimulants.  
 
The remainder of the paper is divided into several sections. The first 
describes the supply context for dexamphetamine in WA, which has one of 
the highest rates of dexamphetamine prescription in the world. Through a 
brief review of existing epidemiological evidence, we also show how 
recreational use of dexamphetamine (diverted from ADHD prescriptions) is 
higher amongst psychostimulant-using young adults in WA than in other 
Australian jurisdictions. In the second and third sections, we outline the 
ethnographic methods used in the study and summarise the 
sociodemographic characteristics and drug use patterns of our sample.  
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Next, we show that dexamphetamine has been integrated into local drug 
practices and explore the ways in which its use is rationalised, negotiated and 
represented in the context of the use of alcohol and other psychostimulants 
such as methamphetamine and ecstasy. Drawing on ethnographic data, we 
argue that dexamphetamine use is considered insignificant, is perceived as 
‘safer’ than the use of other drugs and plays an instrumental role in facilitating 
the pursuit of ‘controlled pleasure’ via heavy consumption of alcohol and other 
drugs. We argue that these patterns of use have implications for harm 
reduction, and these are explored in our conclusion. 
 
The prescription and use of pharmaceutical stimulants in WA 
Between 1994-2000, Australia’s licit consumption of psychostimulants was the 
third highest in the world behind the United States (US) and Canada (when 
standardised) (Berbatis, Sunderland, & Bulsara, 2002, p.540). Of particular 
significance for this paper is that, within Australia, WA has markedly higher 
prescription rates for dexamphetamine than any other Australian jurisdiction.  
WA’s dexamphetamine prescriptions from 1984-2000 increased by an 
average of 43% per year compared to a combined average of 27% for other 
Australian jurisdictions (Berbatis et al., 2002, p.541). Indeed, prescription 
rates in WA are among the highest in the world, similar to that of the US and 
Canada (Berbatis et al., 2002, p.541). The same dataset also shows that 
dexamphetamine represents the majority of prescriptions for psychostimulants 




A 2003 inquiry, conducted by the WA Government, drew a link between high 
prescription rates, the prescribing practices of a small number of medical 
practitioners and adherence to the US model of medicating a wider ‘spectrum’ 
of ADHD symptoms (Government of Western Australia, 2004).The inquiry led 
to greater monitoring and tightening of prescribing practices in WA through 
the establishment of a ‘stimulants’ committee of medical professionals, the 
introduction of regulatory measures and audits, and the funding of further 
research (Calver, Preen, Bulsara, & Sanfilippo, 2007; Department of Health, 
2002, 2005a, 2005b; Preen, Calver, Sanfilippo, Bulsara, & Holman, 2007). 
These measures have resulted in slightly lowered rates of prescription among 
children in WA, although there has been a significant rise in adult 
prescriptions (Department of Health, 2007). 
 
Annual national surveys conducted for the Ecstasy and related Drugs 
Reporting System (EDRS) also indicate that recreational use of 
pharmaceutical stimulants by young adults in WA is far greater than in other 
Australian jurisdictions (Breen et al., 2004; Dunn et al., 2007; Stafford et al., 
2005). For example, in 2005, rates of recent use in the WA EDRS sample 
peaked at 74% compared to 25% in a national sample (the national sample 
also included WA, so the actual discrepancy is even greater) (Stafford et al., 
2006). Another study (conducted as part of the multi-site, multidisciplinary 
project of which this research was also a component) also reported that the 
prevalence of recent use of pharmaceutical stimulants was 10% in a 
Melbourne sample compared to 71% in a Perth sample (Jenkinson, Dietze, & 
Jolley, 2007). While previous research has established the ready availability 
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of pharmaceutical stimulants in WA, and the high prevalence of their use 
amongst young adults, little data is available on the social and cultural 
contexts of this use. 
 
Methods 
Between December 2005 and June 2007, the first author (RG) conducted 
ethnographic fieldwork with a social network of approximately 60 young adults 
who used psychostimulants (particularly ecstasy and methamphetamine). 
This network consisted of several clusters of close relationships, which were 
linked to the other clusters by ‘weak ties’ (Granovetter, 1983). Ethics approval 
was granted by Curtin University of Technology’s Human Research Ethics 
Committee. Beginning with two individuals known to her through her own 
social networks, RG relied on peer-based networking and referral to establish 
relationships with members of the network.  
 
Data collection involved two components: participant observation and in-depth 
interviews. The fieldwork component involved regular interaction by RG with 
members of the social network in natural settings as they engaged in drug use 
and related leisure activities. Typical settings in which drugs were used 
included nightclubs, festivals and other outdoor music events, private parties 
and social gatherings, and public spaces. RG’s involvement also extended to 
leisure activities that did not necessarily involve drug use (e.g. barbeques and 
dinners). This broader participation in the social network provided 
opportunities to understand how drug use was positioned within the overall 
context of people’s lives, to develop relationships with individuals outside drug 
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use settings and to observe network social processes. Detailed fieldnotes 
were recorded following each observation ‘session’. Throughout the course of 
fieldwork, fieldnotes were analysed for emerging themes, insights, 
contradictions and divergence. This ongoing analysis then informed future 
data collection thereby influencing the course and direction of the study.  
 
In order to pursue key themes arising during the participant observation, and 
to gather personal narratives of involvement in drug use, RG also conducted 
semi-structured, in-depth interviews with 25 members of the network, who 
were selected on the basis of their relationship with RG, influence within the 
network and their availability. Themes covered in the interviews included how 
different social contexts shaped drug use, the negotiation, regulation and 
transformation of drug use over time, and perceptions of drug-related benefits 
and harms. Interviews were digitally recorded and professionally transcribed. 
All fieldnotes and interview transcripts were managed using NVivo7 software 
and subjected to open and axial data coding (Strauss & Corbin, 1998). 
Analysis was informed by research on the ‘normalisation’ of drug use 
(Cameron Duff, 2003; Parker, 2005) and on ‘controlled’ drug use (Mugford, 
1991; Zinberg, 1984). 
 
Network demographics and patterns of drug use 
The demographics of the young adults involved in this research are similar to 
the profiles of typical ‘party drug’ users reported in Australian quantitative 
studies. The majority were engaged in full-time work or study (or both), and 
many had tertiary qualifications. Approximately 60% were male and the 
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majority were of Anglo-Celtic background and heterosexual. Their ages 
ranged between 18-31 years old, while the average age of the 25 
interviewees was 24 years old. Individual patterns of drug use varied 
significantly over time: the frequency of use fluctuated widely, the amounts 
used in specific sessions varied and drug preferences changed.  
 
Within this variation, however, we identified two main styles of drug use and 
found that movement between them was common during the fieldwork period. 
‘Regular’ use involved use of psychostimulants at least monthly and 
encapsulated the majority of young adults involved in the research. 
‘Occasional’ use, as the name suggests, involved less frequent 
psychostimulant use – that is, use every 1-6 months. Among regular users, 
drug use was oriented around the working week/weekend cycle with public 
holidays and periods of leave from work or university breaks being times of 
increased use. One defining feature of regular use were frequent ‘benders’, 
which typically occurred across a weekend (1-3 nights) and involved 
significant polydrug use with little or no sleep. By comparison, among those 
who used drugs only occasionally, ‘benders’ were rare. Exceptions included 
large music events, special occasions or extended holiday periods. 
 
Though there are many commonalities in the characteristics of ‘regular’ and 
‘occasional’ drug use (when considering types of drugs used and typical 
contexts for use), the main difference was the extent to which drug use took 
priority over other aspects of life. Regular drug use involved a significant 
investment of resources (ie, time, money and energy) in the pursuit of 
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‘partying’. Frequent attendance at nightclubs and electronic music events 
often took precedence over work, study, non-drug involved friendships and 
family. Those who used drugs occasionally tended to prioritise their non-drug 
commitments, often choosing to socialise in private with partners or close 
friends. This group tended to value their weekends as an opportunity to 
refresh themselves following the working or study week, pursue sporting 
interests and socialise with family, friends and partners unhindered by the 
after-effects of drugs. Other distinguishing features of the regular drug-using 
style were more extensive polydrug use and participation in ‘risky’ and 
potentially stigmatising activities such as smoking methamphetamine (in 
either powder or crystalline form). 
 
Being predominantly Anglo-Celtic and middle-class, these young adults held 
many shared cultural values. One key notion was that ‘party drug’ use was 
only acceptable on weekends or during holidays. The theme of personal 
control is central to experiences of drug use (whether of the ‘regular’ or 
‘occasional’ kind) and network members were aware of the potentially 
detrimental effects of ‘unchecked’ drug use to their health, interpersonal 
relationships, employment/careers and financial goals. They were also acutely 
aware that uncontrolled drug use had the potential to damage their status 
within ‘mainstream’ society. For these reasons, the maintenance of 
‘controlled’ or ‘functional’ drug use was much valued by network members. 
 
The majority of network members regularly engaged in ‘risky’ or ‘heavy’ 
drinking, defined in the National Health and Medical Research Council 
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guidelines as the consumption of more than six standard drinks in a day for 
males and four for females (in Australia, one standard drink is 10g of alcohol)  
(Commonwealth of Australia, 2001, p.35). The most commonly used illicit 
drugs, following cannabis, were ‘rock’, ‘crack’ or ‘meth’ (crystalline 
methamphetamine, usually smoked in a glass pipe), ‘speed’ 
(methamphetamine powder, usually snorted) and ‘pills’ (ecstasy tablets, 
usually swallowed). Six people had previously injected drugs, two on a regular 
basis (injecting was heavily stigmatised among this network and so may have 
been more widespread than reported). Recreational use of diverted 
prescription opiates and benzodiazepines was not common, though they were 
occasionally used to manage the ‘comedowns’ from psychostimulants. In 
addition to the primary use of methamphetamine and ecstasy, use of 
dexamphetamine was very prevalent among both regular and occasional drug 
users. 
 
Sourcing and using ‘dexies’ 
Commonly known as ‘dexies’, ‘d5s’ (referring to the inscription on the tablet) 
or simply ‘dex’ or ‘d’, dexamphetamine has been, for almost all members of 
the network, an integral element of the drug landscape throughout their drug 
careers. The sourcing of dexies was often covert and occurred directly 
between individuals possessing medical prescriptions and those seeking a 
recreational supply. These transactions, while rarely the topic of lengthy 
discussion, were observed frequently during ethnographic fieldwork. Below is 
an excerpt from RG’s fieldnotes:   
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Nick lined up some dexies from Cameron [who held a prescription] when we 
got into [Pub X] on Saturday night. The discussion was brief – something like 
“hey mate do you have any ds on you tonight?”, Cameron said “yeah, I’ll 
throw you some later”. Later in the night Cameron went over to Nick and 
slipped two or three white pills into Nick’s top pocket without saying anything. I 
think I was one of the only people who even noticed. 
 
Dexies were most often given as ‘gifts’ by the prescription holder or 
incorporated into reciprocal exchanges of alcohol or other drugs between 
friends. If sold for money, dexies were usually priced at AU$1-2 per tablet. 
 
There were five individuals in the studied network who held dexamphetamine 
prescriptions, three of whom participated in in-depth interviews. All of them 
filled their prescriptions but did not always use dexamphetamine strictly as 
medically prescribed (sometimes using it for recreational purposes). The three 
individuals interviewed all questioned the precision of their ADHD diagnoses 
and used dexamphetamine according to their own assessments of need. 
 
For these five individuals, managing their supplies of dexies required 
considerable coordination, particularly as dexies were a popular commodity in 
the illicit drugs landscape and all were concerned that they could find 
themselves ‘short’ if they gave away or sold too many. For these reasons, 
those with a prescription were somewhat selective about who they gave or 
sold their dexies to, and only rarely sold them to strangers (for the increased 
sum of AU$2-5 per tablet). Very occasionally, whole bottles of dexies 
(containing 100 tablets) were sold for between AU$200-400. Such sales 
delivered a significant profit to the seller because the subsidy provided by the 
Pharmaceutical Benefits Scheme meant that bottles cost under AU$15. 
 
 14 
Throughout fieldwork, those with dexamphetamine prescriptions (and even 
those with access to prescriptions through partners or close friends) spoke 
about the burden of being ‘the person [in their social network] with a dexies 
prescription’. Reluctantly placed in the role of ‘dealer’, they often felt harassed 
and overwhelmed with requests to supply friends with dexies. Various 
strategies were used to negotiate these requests – telling people that they 
‘don’t have the prescription anymore’, that they have ‘run out’ or that they 
‘need the rest’ for their own medical needs. 
 
Although usually swallowed whole, dexies were occasionally crushed into a 
powder and snorted to achieve a quicker onset of effects. Availability and 
individual preferences determined the level of use but 1-5 tablets was a 
common amount to use ‘at a time’ or ‘in a night’. This is consistent with data 
obtained from a pharmaceutical stimulant component of the 2007 EDRS, 
where the median number of dexamphetamine tablets reportedly consumed 
on the last occasion of use was three (Fetherston, 2007). It was rare for an 
individual to take more than ten tablets in one session. 
 
‘They’re not really worth talking about’: Cultural understandings of 
dexies 
To the young adults involved in this study, dexamphetamine use was not 
regarded as especially noteworthy and was often absent from their 
discussions about drug use (hence our emphasis in this paper on data from 
in-depth interviews). Underpinning this ambivalence was a conceptual ‘scale’ 
by which drugs were ordered from ‘least’ to ‘most risky’. At the risky end of the 
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scale was the injection of heroin, which was widely associated with loss of 
personal control, ill-health and degradation. At the other end of the scale were 
pharmaceuticals, which were seen as subject to stringent quality control, 
available in measured doses and usually taken under medical supervision. 
Methamphetamine, cocaine, ecstasy and illicit drugs other than heroin were 
positioned somewhere in between, recognised as potentially risky but also as 
familiar and commonplace components of the leisure landscape. When 
smoked, methamphetamine was positioned at the more serious end of the 
scale. Given its widespread use, cannabis was positioned at the low-risk end 
of the scale. 
 
Alcohol occupied a complex and contradictory position in relation to risk. As a 
legal, widely-available and socially sanctioned drug, it was sometimes placed 
at the low-risk end of the scale. However, network members also 
acknowledged high levels of overall harm attributable to alcohol use in their 
network and the wider community, and often spoke about alcohol use as 
therefore ‘worse’ than methamphetamine and ecstasy. This suggests a 
general perception that all drugs had the potential to cause harm, particularly 
when used in excess. 
 
Guided by their understanding of dexamphetamine as a pharmaceutical, and 
as a relatively benign drug, its use was often overlooked by network 
members. Below is an excerpt drawn from RG’s fieldnotes. It involves one of 
RG’s closest male participants, Trevor (a pseudonym, as are all names used), 
a 25 year old professional: 
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Last weekend Trevor and I had a conversation about the number of ‘large’ 
upcoming music events (three or four). He spent some time discussing the 
merits of each event to me – which djs he was looking forward to seeing, 
which djs he thought I would enjoy, and offered to get me cheap tickets. 
He planned to go most of these events. I commented on the high price of 
the tickets and Trevor agreed. He said to me that he would ‘probably not 
go out as much’ until then – ‘just to save and yeah... just have a break and 
stuff’ (he was talking about having a break from drug use, an intention that 
he had spoken with me about previously also).  
 
This Friday night Trevor invited me to come along with him to Club A. It 
was a regular Friday night at Club A - one of the locals was playing [‘local’ 
meaning a Perth dj as opposed to an international act] and we knew the 
usual crowd would be there. 
 
I sat around most of the night chatting to everybody, moving around 
between small groups (it’s so loud inside that usually conversations can 
only happen in groups of two or three). Throughout the night I occasionally 
came back to Trevor, who was sipping on his favourite beer. At the end of 
the night he said that he had three (standard for him - he is not a big 
drinker). At about 2:30am he started to spend more time on the edge of 
the dance floor, standing and watching the dj, drink in hand. By 4:30/5am 
he was dancing with some friends right in the middle of the dance floor. 
The dj was playing heavy drum and bass – Trevor’s favourite style of 
music. He came off the dance floor, red, sweating and said that he was 
going outside. I accompanied him while he had a cigarette and sipped on 
a water bottle. 
 
I was curious as to whether he had kept to his decision to take a break? 
This wasn’t one of the music events that he had been looking forward to, 
yet he was wide awake at 5am and was talking about going back to 
somebody’s place ‘for a bit’, and I thought that he may have taken 
something. I said to him, ‘Trevor I don’t know how you are so energetic… 
you haven’t taken anything tonight?’ He responded, ‘nah, just a couple of 
dexies.’ 
 
Trevor’s covert dexamphetamine use and his offhand remark about it were 
typical within this social context. Among network members, there was a 
culturally ambivalent attitude towards dexamphetamine and resistance to 
identifying it as a ‘drug’ was widespread. When RG asked network members if 
they had taken any illicit drugs on particular nights, she was repeatedly told, ‘I 
haven’t taken anything tonight … Oh, just dexies’. 
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The ambivalence towards dexamphetamine and the reluctance to view its use 
as ’significant’ is further illuminated in the following example involving Melissa. 
When RG first told Melissa about the research, Melissa said, ‘I’m sorry, I don’t 
think I’ll be much help to you, I don’t really use drugs’. Over time, however, 
field observations revealed that Melissa attended music events on a weekly 
basis, where she would drink alcohol and use dexies. During an in-depth 
interview, Melissa spoke about her decision to use dexies even though she 
‘didn’t use drugs’. She said of dexies: 
[A friend of hers] just always had them on him and it would be like asking 
someone, ‘Would you like a mint?’, you know? It was like, ‘yeah, ok’. 
 
In comparing dexies to mints, Melissa detaches them from the discourse of 
illicit drug use (i.e. from notions of furtive ‘dealing’ and ‘scoring’, and 
considerations of quality, amount and price) and emphasises their 
acceptability and the casual way in which they are offered and used.  
 
Melissa was not alone in expressing such sentiments. When prompted on the 
subject of dexies during an in-depth interview, Liz, another network member, 
replied, ‘Well, they’re not really worth talking about’. These comments were 
consistent with RG’s ethnographic observations that use of dexies was 
considered to be ‘no big deal’; their use was not considered particularly 
noteworthy or significant by network members when compared with the use of 
other illicit drugs. Dexies were seen as ‘kiddie drugs’; if prescribed to children, 




Dexamphetamine use was also deeply embedded in the discourse of 
personal control that we outlined earlier and this was intimately linked to its 
status as a medical drug. The prescription quality of dexamphetamine 
enabled individuals to control the dose taken with a high degree of precision 
and it was in this context that dexamphetamine was interpreted as ‘safer’ than 
illicit ‘street’ drugs such as methamphetamine. The perception that dexies are 
‘better’ than other drugs (as in less damaging to one’s health) was common, 
and this informed a preference for their use among some occasional drug 
users, who were often more cautious and concerned with the health 
implications of drug use than regular drug users. 
 
The pharmaceutical quality of dexies provided a clear rationale for their use in 
preference to other drugs. For example, Calvin said, during an interview: 
[E]ven today they're actually probably one of my favourites because it’s cheap 
and it’s effective and it doesn’t make you feel bad. It’s a pharmaceutical 
product, it’s like it’s a controlled substance so it’s kind of…yeah it seems to 
me that when you have them it’s sort of... you kind of know how you’re going 
to feel whereas when you have pills [ecstasy] and stuff like that [e.g. speed] 
the effects and the duration and stuff like that can change from time to time. 
 
Similarly, when asked if he had a preference for dexies over speed, Max had 
this to say: 
Absolutely. It’s a prescription drug, I know what I’m getting every time. I know 
how I’m going to react to them every time.  
 
Again, however, these statements must be viewed in the context of wider 
drug-related practices, as the interpretation of dexies as ‘safe’ was only 
relative to the use of other illicit drugs. While dexies were frequently described 
as ‘kiddie drugs’, network members also frequently experienced acute 
negative side-effects from their use – such as nausea, stomach cramps, 
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headaches and ‘comedowns’ – which were likened to those following the use 
of methamphetamine or ecstasy. Some individuals avoided dexamphetamine 
and others limited their use in any particular session because of these side-
effects. Many network members spoke about their experiences of a range of 
health problems that they had recently experienced. These included 
especially low mood/swinging moods, anxiety, panic attacks, depression, 
sleep problems and compromised immune systems. Though it was 
acknowledged that using “gear” (meaning psychostimulant drugs) was related 
to these outcomes the link was rarely drawn between these experiences and 
dexamphetamine use, 
, outcomes that they also linked to psychostimulant use more generally. 
 
‘Getting messy’ versus ‘keeping a lid on it’: Dexamphetamine and the 
pursuit of controlled pleasure 
Several recent studies have focused on alcohol and other drug use amongst 
young adults in the United Kingdom (e.g. Measham, 2004, 2006; Measham & 
Brain, 2005; Szmigin et al., 2008). According to these studies, aggressive 
alcohol marketing, the cultural normalisation of alcohol and other drug 
intoxication, and changes in night-time leisure economies have meant that 
young adults must negotiate complex contradictions between a market-driven 
society that emphasises excessive consumption and the increasing social 
regulation of such consumption. They negotiate these contradictions through 
what has been termed ‘calculated hedonism’ or a ‘controlled loss of control’, 
where apparently ‘excessive consumption’ of alcohol and other drugs remains 
bounded by space, time and social situation (Measham, 2004). Young adults 
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balance the desire for ‘having fun’, ‘letting go’ and ‘taking risks’ within the 
constraints imposed by study, work and family, and try to avoid risking their 
social and cultural credibility by ‘getting messy’ through drinking and/or drug 
use at inappropriate times or too frequently. These contradictions need also 
to be seen against a ‘backdrop of heightened uncertainties about identity and 
the journey to adulthood by young adults in contemporary society’ (Measham, 
2006, p.261). 
 
Negotiating a form of controlled pleasure in relation to drug use was also a 
key concern for members of the studied social network. They categorised 
drugs according to the ease with which their physiological and psychological 
effects could be controlled, and how peers were likely to perceive their 
behaviour when intoxicated. Drugs that, by virtue of their pharmacological 
properties, were used to ‘get messy’ or ’messed up’ were distinguished from 
those that delivered a more controlled experience, which was sometimes 
described as ‘keeping a lid on it’. 
 
Despite its widespread use, alcohol was categorised as the quintessentially 
‘messy’ drug. Among network members (as is common among young adults 
in Australia more generally), ‘binge drinking’ among males and females 
occurred frequently. However, the decreased motor control, depressant 
effects and ‘drunken’ behaviour (eg, passing out or vomiting) associated with 
excessive alcohol consumption were seen as undesirable, especially in the 
context of electronic music events. Such events usually ran all night and 
involved long periods of socialising and dancing.  
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Interestingly, during fieldwork it became clear that ecstasy had also come to 
be categorised as a potentially ‘messy’ drug (see also C Duff, Johnston, 
Moore, & Goren, 2007). The visible effects of ecstasy intoxication (known 
among this group as ‘gurning’, a term primarily referring to contorted facial 
expressions), and the emotional closeness expressed in hugging friends, 
were seen as indicating a loss of personal control, and as potentially 
embarrassing and inappropriate. Although ecstasy was still used occasionally 
in nightclubs or at dance parties, particularly by younger members of the 
network, its use was increasingly confined to private settings among more 
experienced drug users. 
 
By contrast, methamphetamine was seen as facilitating controlled drug 
experiences. In the following interview extract, Liz compares 
methamphetamine’s effects with those of ecstasy and alcohol: 
Liz: I find that the rock [crystal methamphetamine] just doesn’t affect my 
emotions at all. The E affects your emotions and that’s not what I was after. I 
wanted to be in full control of what I was doing, what I was feeling.  
Rachael: Okay so what you’re describing is choosing a drug that would suit 
exactly the state that you wanted to be in to go out and listen to music and 
socialise, right? 
Liz: Yeah, pretty much something that leaves you with control of your 
facilities, because there’s nothing I hate more than a drunk girl. They’re loud 
and squealy. I don’t drink that much either, you know what I mean. 
 
Likewise, Gretel also voices a preference for controlled drug experiences: 
There was a day where I used to say that pills were so much better than 
everything else … but I think I would definitely have a preference for 
something where I’m still able to have my state of mind intact; where I know 
what’s going on rather than being not completely but almost out of control. 
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The effects of dexamphetamine were well-suited to this desire for controlled 
pleasure. In particular, its unadulterated stimulant effect was widely 
appreciated for its ability to provide a counterpoint to alcohol intoxication and 
it was often used to ‘straighten’ one out during and after heavy drinking. For 
example, when asked whether he would drink and take dexies, Ryan said:  
I have done in the past and you can drink like a trooper. You can drink a lot of 
alcohol and you don’t feel drunk … you don’t get the whole drunk, drowsy – 
you get the drunk feeling, but not the fatigue associated [with it]. 
 
Similarly, Fiona said that the combination of alcohol and dexies was ‘great’: 
Coz you can drink and you don’t get that that slurring, stumbling thing, you 
can drink so much more… but you still get that Dutch courage kind of chatty. 
 
Likewise, Henry said he liked dexies because: 
Dexies really stimulated you. It got you thinking and going. It kept you awake. 
When you mix them with alcohol you get all the great effects of being drunk 
without the stupor involved. 
 
For Ryan, Fiona and Henry, and for many of their peers, using dexies enabled 
them to experience the pleasures of alcohol intoxication while, at the same 
time, controlling some of its negative or ‘messy’ effects – that is, to experience 
controlled pleasure. The ability to ‘drink like a trooper’ while maintaining bodily 
control was celebrated and using dexies allowed individuals to enjoy 
socialising for longer periods without getting too ‘messy’. Female participants 
also noted that they felt safer and ‘more in control of the situation’ (eg, in 
night-time environments) when using stimulants in conjunction with alcohol. 
These benefits were also useful in more formal social or work-related 
situations where heavy drinking was involved yet presentation of a controlled 
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self was valued. Dexamphetamine use was also often concealed from peers 
or used ‘on the sly’, for example, to enhance drinking prowess. 
 
A final aspect of dexamphetamine use was its largely instrumental nature and 
its cultural detachment from notions of pleasure. While it was culturally 
appropriate to speak of ecstasy-related ‘highs’, it was deemed ‘pathetic’ to 
speak about ‘highs’ in relation to dexamphetamine. When discussing drug 
use, individuals often spoke about using dexies ‘just’ to stay awake. The 
measured dose of dexies allowed precise calculations to be made of the 
amount of time likely to be invested in the social experience and the post-
intoxication period. As Gretel said during an interview:  
I know if I’ve taken x amount of dexies I’m not going to sleep until x o’clock um 
but I don’t get a comedown off them at all which is why I actually have a 
preference with them. 
 
She highlights the ability to control the experience as the main reason for 
using dexies.  
  
The instrumental use of dexamphetamine also manifested in the polydrug 
using environment. Dexies were often incorporated in ‘the mix’ during heavy 
drug-using sessions but were seen as just one element of the experience 
rather than as its highlight. For example, they were often used to ‘smooth out’ 
the ‘crash’ when the effects of an ecstasy pill began to wear off, or to prolong 
the social (and drug) experience – for example, at an after-party. The effects 
of dexamphetamine were rarely described as ‘pleasurable’ but dexies 
facilitated, enhanced and helped to control the pleasures derived from the use 
of other drugs – licit and illicit – and the associated leisure activities. 
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Conclusion: Dexamphetamine use and harm reduction 
In our account, we have focused on three key aspects of recreational 
dexamphetamine use amongst a social network of young adults. First, we 
located our ethnographic analysis within the supply context of Perth, where 
high rates of dexamphetamine prescription – amongst the highest in the world 
– appear to support a pattern of widespread use of diverted dexamphetamine 
amongst young polydrug users. Second, we have shown how network 
members distinguished dexamphetamine use from the use of illicit drugs. 
Ambivalent about its use, they categorised it as ‘safer’ than illicit drugs such 
as methamphetamine and ecstasy on a scale of risk. Third, we have 
described its instrumental role in the pursuit of controlled pleasure and, in 
particular, its facilitation of heavy drinking and/or drug use. In closing, we 
consider the implications of these findings for harm reduction. 
 
First, it should be acknowledged that although psychostimulant use, including 
use of dexamphetamine, was not entirely unproblematic for network 
members, it was not generally associated with widespread, serious or long-
lasting harm. TheyNetwork members Further, the young adults involved in this 
study maintained involvement in ‘mainstream’ society (eg, through 
employment and/or universitytertiary study), were not involved in violent or 
acquisitive crime, recognised the need to regulate their use of 
dexamphetamine and of other psychostimulants, and used dexamphetamine 
to avoid getting ‘messy’, particularly when drinking heavily. Given this style of 
use, and the pharmaceutical status of dexamphetamine, we pose the 
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following question: does dexamphetamine use have harm reduction benefits 
when compared to the use of illicitly-manufactured psychostimulants such as 
methamphetamine? 
 
Second, and notwithstanding dexamphetamine’s reported ability to reduce 
‘messy’ alcohol use, education and harm reduction campaigns might consider 
addressing, in particular, dexamphetamine’s instrumental role in facilitating 
heavy drinking and/or use of other drugs. Like other amphetamines, 
dexamphetamine decreases sensitivity to many of the body’s signs of alcohol 
intoxication and may increase the risk of acute and chronic alcohol-related 
harms (eg, alcohol poisoning, drink-driving and long-term liver damage). 
Concomitant use of psychostimulants with other drugs is also potentially 
harmful (Gouzoulis-Mayfrank & Daumann, 2006) but this information is not 
widely available to young adults. This is a cause for concern given that the 
use of diverted pharmaceuticals in conjunction with alcohol and other drugs is 
common among young adults (Copeland, Dillon, & Gascoigne, 2004). More 
broadly, this study suggests that the maintenance of rigid distinctions between 
licit and illicit drugs may be unhelpful in efforts to reduce drug-related harm. 
 
Third, education and harm reduction campaigns should consider the inclusion 
of material on the use of dexamphetamine (and potentially of other 
pharmaceutical stimulants) and related harms, particularly in contexts of high 
availability – such as Perth, the US and Canada. In Australia, public health 
campaigns have focused mainly on the use of illicitly-manufactured drugs 
such as ecstasy and methamphetamine (particularly crystal 
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methamphetamine or ‘Ice’) and related harms. They have also tended to 
focus on the dangers posed by adulterants in ‘street’ drugs (for example, 
through campaign images of ‘backyard labs’ and an emphasis on dangerous 
contaminants), a warning that is irrelevant in the context of pharmaceutical 
drugs. Furthermore, the common emphasis on the adulterated and illicit status 
of drugs in strategies targeting this group may reinforce the existing belief that 
dexamphetamine is benign in relation to other drugs – that it is a ‘safe’, 
‘controlled’ chemical – and inadvertently encourage greater use. 
 
We have focused in this paper on the recreational use of diverted 
dexamphetamine in a specific geographical setting – a finding that may have 
limited generalisability to other settings. The incorporation of diverted 
pharmaceuticals (including but not limited to pharmaceutical stimulants) in 
polydrug practices among young adults more generally is an area worthy of 
further investigation. This research highlights the need for further qualitative 
research on the social contexts and cultural meanings of such use to inform 
harm reduction measures. 
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